LGALS3 and brain cancer: Borges et al. [9] demonstrated that the evaluation of galectin-3 is helpful in establishing differential diagnoses among pediatric posterior fossa tumors, based on the fact that galectin-3 is highly expressed in several tumors, including brain neoplasms.